Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
39 participants
OBSERVATIONAL
2018-04-06
2019-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Behavioral Therapy for Children and Adolescents With Tourette Syndrome
NCT03621059
Influence of Stress and Psychiatric Symptoms on Children With Tourette Syndrome
NCT04449003
Effectiveness of Symptom Management Application on Parental Care Ability of Children With Tourette Syndrome
NCT06613126
The Effect and Safety of Plum-blossom Needle for Tourette Syndrome
NCT02403258
Parent Behavioral Training for Disruptive Behaviors in Tourette Syndrome
NCT02882490
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
OTHER
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Administration of questionnaires
According to clinical practice, the following questionnaires are administered:
* Y-GTSS
* Y-BOCS or cY-BOCS
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Males and females.
* Age between 6 and 50 (completed).
* Diagnosis of Tourette syndrome ascertained
* Presence of a value equal to or greater than 15/40 of the Y-BOCS.
Exclusion Criteria
* Presence of significant psychiatric symptoms, with the exception of those belonging to the Tourette Syndrome itself (eg ADHD, OCD)
6 Years
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mauro Porta
Role: PRINCIPAL_INVESTIGATOR
IRCCS Orthopedic Institute Galeazzi
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
IRCCS Galeazzi Hospital
Milan, Lombardy, Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
L3036
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
Stagionalità TS (PI: M Porta)
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.